www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Links  |  Webmaster 
Updated Sun, February 1, 2009.
1.www.galenicom.com2010000
2.www.aerzteblatt.de1310000
3.bmj.bmjjournals.com1060000
4.www.pubmedcentral.nih.gov800000
5.www.medicalnewstoday.com547000
6.www.med1.de522000
7.www.emedicine.com481000
8.www.obesityhelp.com393000
9.content.nejm.org371000
10.www.redcross.org343000
11.www.hospital-data.com316000
12.www.medi-learn.de292000
13.www.mdconsult.com285000
14.jama.ama-assn.org282000
15.www.med.univ-rennes1.fr260000
16.www.locateadoc.com250000
17.www.cpsc.gov243000
18.www.nih.gov234000
19.www.med.umich.edu229000
20.www.chestjournal.org226000
21.www.aafp.org215000
22.www.med.nyu.edu204000
23.www.aap.org202000
24.www.aerztlichepraxis.de199000
25.www.medscape.com188000
26.www.aerztestellen.de177000
27.www.gsm.com176000
28.www.efisioterapia.net176000
29.www.ahrq.gov174000
30.www.netdoktor.de164000
31.www.docguide.com161000
32.www.jneurosci.org156000
33.www.emedicinehealth.com155000
34.www.orpha.net154000
35.www.pfizer.com136000
36.www.ninds.nih.gov135000
37.www.gsk.com135000
38.www.medizin-forum.de131000
39.www.e-carabin.net130000
40.www.thieme.de129000
41.www.socialsecurity.gov128000
42.www.valuemd.com125000
43.www.meddean.luc.edu123000
44.www.baua.de122000
45.www.guideline.gov117000
46.ajp.psychiatryonline.org110000
47.www.urmc.rochester.edu107000
48.www.vh.org106000
49.www.obgyn.net102000
50.www.annals.org97700
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 



Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Furl Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Ma.gnolia Add to Newsvine Add to Shadows

34. www.orpha.net

Rating: 154000 points*
*amount mentions of word 'www.orpha.net' on the other websites

www.orpha.net

Orphanet

Description: Database of rare diseases and orphan drugs

Most popular searches: medical research, genome, orphan drug, www.orphan.et, drug rehab, orphan drugs, Pharmaceutical, doctor, www.orhpa.net, wwworpha.net, www.orpha.ent, ww.orpha.net, wwworpha.net, www.orpha.com, medical information, www.ropha.net, Nachrichten, family practice, drug, www.orha.net, rare disorder, www.orpa.net, www.orpha.nt, asthma, obesity, genetic disease, rare diseases, Krankenhaus, Immunology, Allergy, ww.worpha.net, www.orpha.net, ww.orpha.net, cholesterol, patient, rare disease, www.rpha.net, www.orpha.net, health, www.opha.net, wwwo.rpha.net, rare disorders, genetic diseases, medicine, www.orpah.net, www.orpha.et, www.orphanet, vaccines, physician, health care, blood pressure, Cardiac, www.orpha.nte, www.oprha.net, www.orph.anet, www.orph.net, www.orpha.ne, Orphanet

Google

© 2005-2008 www.Top100Medicine.com
FDA Requires Faster Food-Safety Alerts
The FDA launched its electronic food registry for companies to quickly report potential food-borne illnesses to the federal government.
online.barrons.com
FDA Narrowly Clears Melanoma Drug
An FDA panel narrowly backed the use of Schering Plough's Pegintron in patients with advanced melanoma amid concerns about drug side-effects.
online.barrons.com
Drug Makers Face Tougher Measures
The House health-care bill presents more problems for drug makers than legislation in the Senate, but it gives the medical-device industry better breaks.
online.wsj.com
Ziopharm: The Money's in the Bank, So What's Next?
Wall Street Teacher submits:On Friday, December 4th, Ziopharm Oncology Inc. (ZIOP) announced a public offering of 15.5 million common shares and warrants to buy 7.7 million shares in a public offering. The deal was priced @ $3.10 per unit and netted the company approximately $45.2 million. For a micro cap, this was a large, fairly dilutive deal. Common shares now stand at 41,192,287 with a market cap of roughly $125 million.First, the negatives--dilution, dilution, dilution. Rodman & Renshaw, LLC,was involved in the transaction. Experience tells me that they are not the most discriminating firm when it comes to stock placement. Many R & R clients are rumored to have no interest in holding positions long term, but merely flip the shares and strip the warrants in unit deals. This may explain the weak aftermarket performance of the stock. (Currently trading @ $ 3.02) Also, since the warrants are exercisable @ $4.02, there may be a short term cap on the share price. Why the big raise? With $7 million in the bank (pre-raise), I believe that Ziopharm was likely low-balled in any partnering discussions so the public offering may (in the long term) turn out to be the wise decision.Complete Story »
seekingalpha.com
Are Forest Labs' Fans Right?
Forest Labs (FRX) is among the stock picks in this weekend's Barron's. Staff writer Jay Palmer does an excellent job laying out the bull case for FRX shares in Forest Lab's Prescription for Success. An unappreciated pipeline plus a huge cash horde add up to a winning combination. He isn't the first to think so.Forest Labs has been a Lonely Value favorite for exactly these reasons. My first Forest post (See the Forest for its Cash) appeared in June of 2009. At the time, the company had $3 billion in cash and securities (zero debt) against a $7.4 billion market value. Fully 40% of Forest's market value was in cash and marketable securities. In addition, FRX was churning out over $1 billion a year in free cash flow. It still does.Complete Story »
seekingalpha.com